Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Normal Responders”

60 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 60 results

Not applicableActive Not RecruitingNCT06431230
What this trial is testing

School-based HIIT and Dose-Response Effects

Who this might be right for
AdolescentsPhysical ActivityAdipose Tissue+2 more
Wroclaw University of Health and Sport Sciences 600
Post-approval studies (Phase 4)UnknownNCT00417183
What this trial is testing

Comparison of the Long GnRH Agonist Protocol and the Flexible GnRH Antagonist Protocol of Ovarian Stimulation

Who this might be right for
Infertility
Eugonia 300
Not applicableUnknownNCT03917537
What this trial is testing

WGA in Platinum-refractory HNSCC Underwent Nivolumab

Who this might be right for
HNSCC
Chang Gung Memorial Hospital 80
Not applicableWithdrawnNCT02486848
What this trial is testing

Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil

Who this might be right for
Female Pattern Hair LossAndrogenetic Alopecia
Maja Kovacevic, MD
Not applicableUnknownNCT04026282
What this trial is testing

To Investigate the Cumulative Live Birth Rates Using GnRH Antagonist or Agonist Protocol for COS in ART Treatment

Who this might be right for
Sterility
Peking University Third Hospital 888
Not applicableStudy completedNCT01557348
What this trial is testing

An Observational Study of MabThera/Rituxan (Rituximab) and Alternative TNF-Inhibitors in Patients With Rheumatoid Arthritis and an Inadequate Response to a Single Previous TNF-Inhibitor

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 1,239
Not applicableEnded earlyNCT01367691
What this trial is testing

Cardiac MR (CMR) in Cardiac Resynchronization Therapy Non-responders

Who this might be right for
Heart Failure
University Hospital, Bonn 1
Testing effectiveness (Phase 2)Ended earlyNCT05000216
What this trial is testing

COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders

Who this might be right for
Rheumatoid Arthritis (RA)Systemic Lupus Erythematosus (SLE)Pemphigus Vulgaris+6 more
National Institute of Allergy and Infectious Diseases (NIAID) 258
Testing effectiveness (Phase 2)Study completedNCT05018806
What this trial is testing

Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Sanofi 124
Not applicableStudy completedNCT01309282
What this trial is testing

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Sero-Positive Rheumatoid Arthritis Who Are Non-Responders or Intolerant to a Single TNF-Inhibitor (PORTSMAB)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 9
Not applicableLooking for participantsNCT03740503
What this trial is testing

Genomic Investigation of Unusual Responders

Who this might be right for
CancerBreast CancerNon-small Cell Lung Cancer+8 more
University Health Network, Toronto 100
Post-approval studies (Phase 4)Study completedNCT03649061
What this trial is testing

COBRA-Slim With or Without Fast Access to TNF Blockade for Remission Induction in Early RA

Who this might be right for
Arthritis, Rheumatoid
P. Verschueren 276
Not applicableEnded earlyNCT03076723
What this trial is testing

Using Cerebrospinal Fluid Dynamics to Optimize Treatment of Idiopathic Normal Pressure Hydrocephalus

Who this might be right for
Hydrocephalus, Normal Pressure
Umeå University 43
Testing effectiveness (Phase 2)Looking for participantsNCT06596018
What this trial is testing

Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy

Who this might be right for
Breast Adenocarcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University 96
Post-approval studies (Phase 4)Study completedNCT02731560
What this trial is testing

Rituximab (RTX) for Disease Modifying Anti Rheumatic Drug (DMARD) Non-responders in Pakistan: The Pakistan Rituximab Study (PARIS)

Who this might be right for
Rheumatoid Arthritis
Prof. Abid Z. Farooqi 74
Post-approval studies (Phase 4)Ended earlyNCT01316133
What this trial is testing

Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients

Who this might be right for
Lupus Nephritis
Astellas Pharma Korea, Inc. 37
Post-approval studies (Phase 4)UnknownNCT03227419
What this trial is testing

Abatacept vs Tocilizumab for the Treatment of RA in TNF Alpha Inhibitor Inadequate Responders

Who this might be right for
Arthritis, Rheumatoid
Lille Catholic University 224
Large-scale testing (Phase 3)Study completedNCT00693108
What this trial is testing

Androgens for Poor Responders in In Vitro Fertilization

Who this might be right for
Ovarian Response
Hospital Clinic of Barcelona
Not applicableStudy completedNCT04834609
What this trial is testing

Adipose Derived Mesenchymal Stem Cell Characteristics in Anal Fistulas

Who this might be right for
Perianal FistulaAdipose TissueTissue Transplantation
University of Aarhus 27
Large-scale testing (Phase 3)WithdrawnNCT01734863
What this trial is testing

Post-operative Radiotherapy in Poor Responders Ewing's Sarcoma Patients

Who this might be right for
Ewing's Sarcoma
Children's Cancer Hospital Egypt 57357
Load More Results